Journey Medical (DERM) Accounts Payables (2020 - 2026)

Journey Medical (DERM) has reported Accounts Payables for 7 consecutive years, with $8.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accounts Payables fell 36.89% year-over-year to $8.0 million; the trailing twelve-month figure through Jun 2026 stood at $8.0 million (down 36.89% YoY), and the FY2025 full-year result was $8.9 million, down 44.85% from the prior year.
• Accounts Payables fell to $8.0 million in Q2 2026 per DERM's latest filing, from $8.2 million in the prior quarter.
• Across five years, Accounts Payables topped out at $43.7 million in Q1 2023 and bottomed at $8.0 million in Q2 2026.
• Historically, Accounts Payables has averaged $20.9 million across 5 years, with a median of $15.7 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Accounts Payables surged 61.94% in 2023, then tumbled 64.86% in 2024.
• Over 5 years, Accounts Payables stood at $36.6 million in 2022, then tumbled by 50.37% to $18.1 million in 2023, then dropped by 11.57% to $16.0 million in 2024, then tumbled by 44.85% to $8.9 million in 2025, then declined by 9.06% to $8.0 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $8.0 million, $8.2 million, and $8.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.